PMID- 17049055 OWN - NLM STAT- MEDLINE DCOM- 20061121 LR - 20230124 IS - 1600-6135 (Print) IS - 1600-6135 (Linking) VI - 6 IP - 11 DP - 2006 Nov TI - The role of hyaluronan degradation products as innate alloimmune agonists. PG - 2622-35 AB - Dendritic cells (DCs) play a key role in initiating alloimmunity yet the substances that activate them during the host response to transplantation remain elusive. In this study we examined the potential roles of endogenous innate immune agonists in activating dendritic cell-dependent alloimmunity. Using a murine in vitro culture system, we show that 135 KDa fragments of the extracellular matrix glycosaminoglycan hyaluronan induce dendritic cell maturation and initiate alloimmunity. Priming of alloimmunity by hyaluronan-activated DCs was dependent on signaling via TIR-associated protein, a Toll-like receptor (TLR) adaptor downstream of TLRs 2 and 4. However, this effect was independent of alternate TLR adaptors, MyD88 or Trif. Using an in vivo murine transplant model, we show that hyaluronan accumulated during skin transplant rejection. Examination of human lung transplant recipients demonstrated that increased levels of intragraft hyaluronan were associated with bronchiolitis obliterans syndrome. In conclusion, our study suggests that fragments of hyaluronan can act as innate immune agonists that activate alloimmunity. FAU - Tesar, B M AU - Tesar BM AD - Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven CT, Connecticut, USA. FAU - Jiang, D AU - Jiang D FAU - Liang, J AU - Liang J FAU - Palmer, S M AU - Palmer SM FAU - Noble, P W AU - Noble PW FAU - Goldstein, D R AU - Goldstein DR LA - eng GR - AI052201/AI/NIAID NIH HHS/United States GR - HL060539/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Transplant JT - American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons JID - 100968638 RN - 0 (Isoantigens) RN - 0 (Myd88 protein, mouse) RN - 0 (Myeloid Differentiation Factor 88) RN - 0 (Oligosaccharides) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 4) RN - 0 (Toll-Like Receptor 8) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9004-61-9 (Hyaluronic Acid) SB - IM MH - Animals MH - Cells, Cultured MH - Dendritic Cells/*immunology MH - Hyaluronic Acid/*immunology/metabolism/pharmacology MH - Inflammation/physiopathology MH - Isoantigens/*immunology MH - Lung Transplantation/immunology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Myeloid Differentiation Factor 88/deficiency/genetics/physiology MH - Oligosaccharides/*immunology/pharmacology MH - Skin Transplantation/*immunology MH - Toll-Like Receptor 4/immunology MH - Toll-Like Receptor 8/immunology MH - Tumor Necrosis Factor-alpha/biosynthesis EDAT- 2006/10/20 09:00 MHDA- 2006/12/09 09:00 CRDT- 2006/10/20 09:00 PHST- 2006/10/20 09:00 [pubmed] PHST- 2006/12/09 09:00 [medline] PHST- 2006/10/20 09:00 [entrez] AID - S1600-6135(22)02871-4 [pii] AID - 10.1111/j.1600-6143.2006.01537.x [doi] PST - ppublish SO - Am J Transplant. 2006 Nov;6(11):2622-35. doi: 10.1111/j.1600-6143.2006.01537.x.